[The pathological processing of prostate biopsy and resection specimens]

Magy Onkol. 2024 Jul 16;68(2):143-153. Epub 2024 May 19.
[Article in Hungarian]

Abstract

Prostate cancer stands as the most prevalent malignant tumor among men; with its incidence increasing with advancing age. The spectrum of patient care options for this disease is broad, encompassing approaches such as "active surveillance," definitive radiation therapy, robot-assisted surgery, among others. These diverse modalities afford opportunities for cure or successful management in the majority of cases. It is paramount to underscore that optimal treatment hinges upon a multidisciplinary framework, wherein the coordinated efforts of allied healthcare professionals yield the highest standard of patient care. Hence, it is imperative for pathologists to keep abreast of contemporary processing and specimen collection protocols, as well as the potential necessity of supplementary investigations and their clinical significance. The latest Hungarian guideline on prostate cancer care features a dedicated chapter delineating the pivotal role and responsibilities of pathologists. Through this discourse, we aim to consolidate and disseminate pertinent insights, thereby fostering the continuing enhancement of pathologists' knowledge and elucidating the intricacies of histological processing to our clinical counterparts.

Publication types

  • Review
  • English Abstract

MeSH terms

  • Biopsy / methods
  • Biopsy / standards
  • Humans
  • Hungary
  • Male
  • Pathologists
  • Practice Guidelines as Topic
  • Prostate / pathology
  • Prostate / surgery
  • Prostatectomy / methods
  • Prostatic Neoplasms* / pathology
  • Prostatic Neoplasms* / surgery
  • Specimen Handling* / methods
  • Specimen Handling* / standards